Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 20;9(9):1036.
doi: 10.3390/nu9091036.

Red Blood Cell Eicosapentaenoic Acid Inversely Relates to MRI-Assessed Carotid Plaque Lipid Core Burden in Elders at High Cardiovascular Risk

Núria Bargalló  1   2 , Rosa Gilabert  3 , Edwin-Saúl Romero-Mamani  4 , Montserrat Cofán  5   6 , Philip C Calder  7   8 , Montserrat Fitó  9   10 , Dolores Corella  11   12 , Jordi Salas-Salvadó  13   14 , Miguel Ruiz-Canela  15   16 , Ramon Estruch  17   18 , Emilio Ros  19   20 , Aleix Sala-Vila  21   22
Affiliations

Red Blood Cell Eicosapentaenoic Acid Inversely Relates to MRI-Assessed Carotid Plaque Lipid Core Burden in Elders at High Cardiovascular Risk

Núria Bargalló et al. Nutrients. .

Abstract

Supplemental marine omega-3 eicosapentaenoic acid (EPA) has an anti-atherosclerotic effect. Clinical research on EPA supplied by the regular diet and atherosclerosis is scarce. In the framework of the PREvención con DIeta MEDiterránea (PREDIMED) trial, we conducted a cross-sectional study in 161 older individuals at high vascular risk grouped into different stages of carotid atherosclerosis severity, including those without ultrasound-detected atheroma plaque (n = 38), with plaques <2.0 mm thick (n = 65), and with plaques ≥2.0 mm (n = 79). The latter were asked to undergo contrast-enhanced 3T magnetic resonance imaging (MRI) and were subsequently grouped into absence (n = 31) or presence (n = 27) of MRI-detectable plaque lipid, a main feature of unstable atheroma plaques. We determined the red blood cell (RBC) proportion of EPA (a valid marker of long-term EPA intake) at enrolment by gas chromatography. In multivariate models, EPA related inversely to MRI-assessed plaque lipid volume, but not to maximum intima-media thickness of internal carotid artery, plaque burden, or MRI-assessed normalized wall index. The inverse association between EPA and plaque lipid content in patients with advanced atherosclerosis supports the notion that this fatty acid might improve cardiovascular health through stabilization of advanced atheroma plaques.

Keywords: atherosclerosis; diet; fish; imaging; omega-3.

PubMed Disclaimer

Conflict of interest statement

Philip C. Calder is an advisor to Pronova BioPharma. Jordi Salas-Salvadó has received research funding and is a non-paid member of the scientific advisory committee of the International Nut Council. Emilio Ros has received research funding from the California Walnut Commission and is also a non-paid member of its scientific advisory committee. No other authors declare a conflict of~interest.

Figures

Figure 1
Figure 1
Flow-chart of the study. “PREDIMED” denotes “PREvención con DIeta MEDiterranea”; “G” denotes group; “MRI” denotes “magnetic resonance imaging”.
Figure 2
Figure 2
Scatter plot of the red blood cell proportion of EPA and plaque lipid core burden.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Naghavi M., GBD 2013 Mortality and Causes of Death Collaborators Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–171. - PMC - PubMed
    1. Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L., Cooney M.T., Corrà U., Cosyns B., Deaton C., et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Eur. Heart J. 2016;37:2315–2381. - PMC - PubMed
    1. Sannino A., Brevetti L., Giugliano G., Scudiero F., Toscano E., Mainolfi C., Cuocolo A., Perrino C., Stabile E., Trimarco B., et al. Non-invasive vulnerable plaque imaging: How do we know that treatment works? Eur. Heart J. Cardiovasc. Imaging. 2014;15:1194–1202. doi: 10.1093/ehjci/jeu097. - DOI - PubMed
    1. Siscovick D.S., Barringer T.A., Fretts A.M., Wu J.H.Y., Lichtenstein A.H., Costello R.B., Kris-Etherton P.M., Jacobson T.A., Engler M.B., Alger H.M., et al. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory from the American Heart Association. Circulation. 2017 doi: 10.1161/CIR.0000000000000482. - DOI - PMC - PubMed
    1. Borow K.M., Nelson J.R., Mason R.P. Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis. Atherosclerosis. 2015;242:357–366. doi: 10.1016/j.atherosclerosis.2015.07.035. - DOI - PubMed

MeSH terms